Source link : https://www.newshealth.biz/health-news/how-do-adcs-affect-safety-and-qol-in-breast-cancer/
TOPLINE: Antibody-drug conjugates (ADCs) were associated with a higher risk for all-grade adverse events (AEs) in metastatic breast cancer than standard therapy, according to a meta-analysis. However, these drugs delayed deterioration in quality of life in almost all domains. METHODOLOGY: Researchers conducted a meta-analysis of nine randomised controlled trials evaluating ADCs vs standard therapy in […]
Author : News Health
Publish date : 2025-02-24 12:00:00
Copyright for syndicated content belongs to the linked Source.